First-in-Human trial tests advanced proton beams to fight tough abdominal tumors
NCT ID NCT06327477
Summary
This study is testing a new, targeted form of proton radiation therapy for people newly diagnosed with a rare abdominal cancer called retroperitoneal sarcoma. The goal is to see if this new technique, which aims to deliver higher radiation doses directly to the tumor while sparing nearby healthy organs, is safe and effective when given before standard radiation and surgery. Researchers will enroll about 28 patients to find the best dose and see if it helps shrink or eliminate the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETROPERITONEAL SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.